Exalgo FDA Approval History
FDA Approved: Yes (Discontinued) (First approved March 1, 2010)
Brand name: Exalgo
Generic name: hydromorphone
Dosage form: Extended Release Tablets
Company: Mallinckrodt Inc.
Treatment for: Pain
Marketing Status: Discontinued
Exalgo (hydromorphone) is a once-a-day extended release opioid formulation for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
Development timeline for Exalgo
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.